Fact CheckerSign in

NCT07266051Not yet recruiting

Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)

Source: ClinicalTrials.gov · Last updated 18 Dec 2025

Brief summary (registry, in English)

This study aims to characterize sex hormone alterations and their potential clinical significance in NMOSD patients from Southern China through comprehensive hormonal profiling.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
4000 (estimated)
First submitted
18 Nov 2025
Start date
Dec 2025
Primary completion date
Jul 2030
Lead sponsor
Xiamen Hospital of Traditional Chinese Medicine
NCT number
NCT07266051

What you commit to

  • Study type: Observational
  • Planned participants: 4000
  • From Dec 2025 to the primary completion date, Jul 2030
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosis of other serious systemic diseases (e.g., malignancy)
  • Presence of severe psychiatric disorders that would preclude compliance with study procedures and/or follow-up assessments
  • History of infectious pathologies of the central nervous system
  • Those with severe liver and kidney function impairment or dysfunction of other vital organs
  • Patients with other conditions that do not allow participation in clinical research
  • Patients allergic to gadolinium-DPTA
  • Patients with other conditions that do not allow participation in clinical research

Who the study is looking for

  • Aged 18 years or older, regardless of sex
  • Fulfilled the diagnostic criteria for Neuromyelitis Optica Spectrum Disorders as defined by the 2021 Chinese guidelines for the diagnosis and management of NMOSD
  • Seropositive for AQP4-IgG
  • Provided informed consent by the participant or their legal guardian
  • Aged 18 years or older, regardless of sex
  • Gender- and age-matched healthy individuals
  • Provided informed consent by the participant or their legal guardian

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Second Affiliated Hospital of Xiamen Medical College
Coordinator of this site? Confirm its status
XiamenChinaUnknown status
Xiamen Hospital of Traditional Chinese Medicine
Coordinator of this site? Confirm its status
XiamenChinaUnknown status
Zhongshan Hospital Xiamen, Fudan University
Coordinator of this site? Confirm its status
XiamenChinaUnknown status
The First Affiliated hospital of Xiamen University
Coordinator of this site? Confirm its status
XiamenChinaUnknown status
Zhongshan Hospital Xiamen University
Coordinator of this site? Confirm its status
XiamenChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.